rYojbaba Co., Ltd. (RYOJ)
NASDAQ: RYOJ · Real-Time Price · USD
2.300
+0.150 (6.98%)
At close: Sep 26, 2025, 4:00 PM EDT
2.260
-0.040 (-1.74%)
After-hours: Sep 26, 2025, 7:56 PM EDT
rYojbaba Market Cap
rYojbaba has a market cap or net worth of $25.88 million as of September 26, 2025.
Market Cap
25.88M
Enterprise Value
33.66M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since the IPO on August 14, 2025, rYojbaba's market cap has decreased from $29.00M to $25.88M, a decrease of -10.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 25.88M | 6.98% |
Sep 25, 2025 | 24.19M | -2.71% |
Sep 24, 2025 | 24.86M | 5.24% |
Sep 23, 2025 | 23.63M | -4.55% |
Sep 22, 2025 | 24.75M | -1.35% |
Sep 19, 2025 | 25.09M | 0.45% |
Sep 18, 2025 | 24.98M | 7.77% |
Sep 17, 2025 | 23.18M | -8.04% |
Sep 16, 2025 | 25.20M | 14.29% |
Sep 15, 2025 | 22.05M | -2.00% |
Sep 12, 2025 | 22.50M | -0.99% |
Sep 11, 2025 | 22.73M | -1.46% |
Sep 10, 2025 | 23.06M | 4.06% |
Sep 9, 2025 | 22.16M | -6.19% |
Sep 8, 2025 | 23.63M | 9.38% |
Sep 5, 2025 | 21.60M | 1.05% |
Sep 4, 2025 | 21.38M | -1.30% |
Sep 3, 2025 | 21.66M | -7.89% |
Sep 2, 2025 | 23.51M | -2.34% |
Aug 29, 2025 | 24.08M | -8.94% |
Aug 28, 2025 | 26.44M | 6.82% |
Aug 27, 2025 | 24.75M | 4.26% |
Aug 26, 2025 | 23.74M | -0.93% |
Aug 25, 2025 | 23.96M | -8.39% |
Aug 22, 2025 | 26.16M | -3.93% |
Aug 21, 2025 | 27.23M | -5.10% |
Aug 20, 2025 | 28.69M | 3.24% |
Aug 19, 2025 | 27.79M | -8.86% |
Aug 18, 2025 | 30.49M | -6.23% |
Aug 15, 2025 | 32.51M | 12.11% |
Aug 14, 2025 | 29.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 641.51B |
Johnson & Johnson | 428.03B |
AbbVie | 386.06B |
UnitedHealth Group | 312.96B |
Novo Nordisk | 251.02B |
Novartis AG | 237.03B |
Abbott Laboratories | 232.02B |
AstraZeneca | 226.78B |